Teva Pharmaceutical Non-GAAP EPS of $0.96 beats by $0.32, revenue of $4.71B beats by $380M

Posted on by wpadmin
  • Teva Pharmaceutical press release (TEVA): Q4 Non-GAAP EPS of $0.96 beats by $0.32.
  • Revenue of $4.71B (+11.3% Y/Y) beats by $380M.
  • FY26 revenue consensus of $16.99B, EPS consensus of $2.77

  • 2026 Business Outlook:

    • Revenues of $16.4 – $16.8 billion
    • Non-GAAP

Leave a Reply

Your email address will not be published. Required fields are marked *